Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly 1 Year Total Returns (Daily) : 77.98% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 77.98% |
| August 20, 2026 | 77.52% |
| August 19, 2026 | 83.22% |
| August 18, 2026 | 76.70% |
| August 17, 2026 | 69.79% |
| August 14, 2026 | 73.89% |
| August 13, 2026 | 84.33% |
| August 12, 2026 | 92.18% |
| August 11, 2026 | 92.62% |
| August 10, 2026 | 98.28% |
| August 07, 2026 | 86.31% |
| August 06, 2026 | 60.82% |
| August 05, 2026 | 53.80% |
| August 04, 2026 | 46.10% |
| August 03, 2026 | 48.13% |
| July 31, 2026 | 56.32% |
| July 30, 2026 | 53.02% |
| July 29, 2026 | 59.71% |
| July 28, 2026 | 52.11% |
| July 27, 2026 | 48.39% |
| July 24, 2026 | 49.54% |
| July 23, 2026 | 49.48% |
| July 22, 2026 | 50.84% |
| July 21, 2026 | 55.30% |
| July 20, 2026 | 49.66% |
| Date | Value |
|---|---|
| July 17, 2026 | 55.93% |
| July 16, 2026 | 49.07% |
| July 15, 2026 | 50.92% |
| July 14, 2026 | 45.20% |
| July 13, 2026 | 50.08% |
| July 10, 2026 | 51.38% |
| July 09, 2026 | 55.73% |
| July 08, 2026 | 57.44% |
| July 07, 2026 | 60.99% |
| July 06, 2026 | 54.80% |
| July 02, 2026 | 56.86% |
| July 01, 2026 | 54.67% |
| June 30, 2026 | 54.94% |
| June 29, 2026 | 59.72% |
| June 26, 2026 | 53.01% |
| June 25, 2026 | 43.33% |
| June 24, 2026 | 44.60% |
| June 23, 2026 | 44.66% |
| June 22, 2026 | 45.50% |
| June 18, 2026 | 40.92% |
| June 17, 2026 | 41.52% |
| June 16, 2026 | 39.97% |
| June 15, 2026 | 38.80% |
| June 12, 2026 | 40.50% |
| June 11, 2026 | 44.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | 54.80% |
| Merck & Co., Inc. | 83.18% |
| Pfizer Inc. | 16.73% |
| Bristol Myers Squibb Co. | 44.96% |
| Atai Beckley, Inc. | 68.11% |